• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number SMART TOUCH BIDIRECTIONAL SF
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 03/24/2022
Event Type  Injury  
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: fakess, s., o' loughlin, m., tolat, a.Left ventricular thrombus following radiofrequency ventricular tachycardia ablation.Heart rhythm case reports 2022;-:1¿4).2022, march 24.Doi:https://doi.Org/10.1016/j.Hrcr.2022.03.013.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.Manufacturer's ref #: (b)(4).
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: fakess, s., o' loughlin, m., tolat, a.Left ventricular thrombus following radiofrequency ventricular tachycardia ablation.Heart rhythm case reports 2022;-:1¿4).2022, march 24.Doi:https://doi.Org/10.1016/j.Hrcr.2022.03.013.Objective/methods/study data: radiofrequency catheter ablation (rfca) has become a mainstay in the treatment of both atrial and ventricular tachyarrhythmias since first being developed in 1986.Over 235,000 ablation procedures are performed annually, with 7% of procedures being for ventricular tachycardia (vt) or premature ventricular contractions (pvc), a percentage that continues to grow.1 as experience in ablation techniques has grown, associated complications have become less common, but they remain an area of focus as the field advances.Thrombus formation is one such complication commonly associated with rfca, with an incidence of 0.6%¿0.8%, a risk that grows to 2.0% for the ablation of ventricular tachyarrhythmias.2 despite its being a relatively rare complication, the clinical sequelae of thrombus formation can be devastating, prompting a recent resurgence in the study of post-ablation thrombogenesis and treatment.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool stsf.Other biosense webster devices that were also used in this study: n/a.Non-biosense webster concomitant devices that were also used in this study: baylis trans-septal needle.Adverse event(s) and provided interventions: a 43-year-old male patient developed a thrombus extending a length of 4.0 x 3.5 cm with a thickness of 0.6 cm post ablation, it was not present on the computed tomography performed prior to the procedure.Following this discovery, the patient was started on apixaban 5 mg twice daily for 1 month.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez
MX  
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14795986
MDR Text Key295069650
Report Number2029046-2022-01422
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSMART TOUCH BIDIRECTIONAL SF
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BAYLIS TRANS-SEPTAL NEEDLE
Patient Outcome(s) Life Threatening;
Patient Age43 YR
Patient SexMale
-
-